GLP-1 prescriptions reach all-time high as Lilly and Novo scramble to keep pace with demand More US patients than ever are being prescribed GLP-1 weight loss medications each week, and biopharma experts have increased their annual sales forecasts of the Sign up to read this article for free
While semaglutide activates only the GLP-1 receptor, tirzepatide simultaneously activates both GLP-1 and GIP receptors, providing dual pathway stimulation
One patient observed the relief of feeling as if they were doing something active following long waiting periods
In a trial, participants follow a research protocol
If you have been looking for a Dr
However, the complexity of these medications, their potential side effects, and the importance of comprehensive treatment approaches underscore the critical need for specialized medical supervision that only qualified weight loss doctors can provide